Symprove (Probiotic) as an add-on to COVID-19 Management
Launched by KING'S COLLEGE HOSPITAL NHS TRUST · May 6, 2021
Trial Information
Current as of June 06, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Symptomatic patients who are hospitalised with respiratory COVID-19
- • Ability to give informed consent
- • Aged 20-85
- Exclusion Criteria:
- • Patients not meeting the inclusion criteria that have COVID-19
- • Inability to consent
- • Pregnancy
- • Severe pre-existing mental health disorders or addictions
About King's College Hospital Nhs Trust
King's College Hospital NHS Trust is a leading healthcare institution in the United Kingdom, renowned for its commitment to providing high-quality patient care and advancing medical research. With a strong emphasis on clinical excellence, the Trust supports a wide range of clinical trials across various specialties, leveraging its state-of-the-art facilities and a multidisciplinary team of healthcare professionals. By fostering innovation and collaboration, King's College Hospital NHS Trust aims to enhance treatment options and improve outcomes for patients, while contributing to the global body of medical knowledge through rigorous scientific investigation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials